Results 81 to 90 of about 1,143 (109)

A systematic review of clinical efficacy and safety of cell-based therapies in Alzheimer's disease. [PDF]

Dement Neuropsychol
Feizi H, Hosseini MS, Seyedi-Sahebari S, Karimi H, Mosaddeghi-Heris R, Sadigh-Eteghad S, Sadeghi-Ghyassi F, Talebi M, Naseri A, Salehi-Pourmehr H, Roshangar L.   +10 more
europepmc   +1 more source

Global burden of young-onset Alzheimer's disease and other dementias: a secondary analysis of the global burden of disease study, 2019. [PDF]

Dement Neuropsychol
Rojas-Gualdrón DF, Henao MS, Zuluaga CAU, Henao AE, Henck CAG.   +4 more
europepmc   +1 more source

Is Montreal Cognitive Assessment a valuable test for the differentiation of Alzheimer's disease, frontotemporal dementia, dementia with Lewy body, and vascular dementia? [PDF]

Dement Neuropsychol
Afrashteh F, Almasi-Dooghaee M, Kamyari N, Rajabi R, Baradaran HR.   +4 more
europepmc   +1 more source

Use of anti-amyloid therapies for Alzheimer's disease in Brazil: a position paper from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. [PDF]

Dement Neuropsychol
Barbosa BJAP, Resende EPF, Castilhos RM, Borelli WV, Frota NAF, Balthazar MLF, Amato ACS, Smid J, Barbosa MT, Coutinho AM, de Souza LC, Schilling LP, da Silva MNM, Fernandes GBP, Bertolucci PHF, Nitrini R, Engelhardt E, Forlenza OV, Caramelli P, Brucki SMD, Studart-Neto A.   +20 more
europepmc   +1 more source

Guidelines for the use and interpretation of Alzheimer's disease biomarkers in clinical practice in Brazil: recommendations from the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. [PDF]

Dement Neuropsychol
Studart-Neto A, Barbosa BJAP, Coutinho AM, de Souza LC, Schilling LP, da Silva MNM, Castilhos RM, Bertolucci PHF, Borelli WV, Gomes HR, Fernandes GBP, Barbosa MT, Balthazar MLF, Frota NAF, Forlenza OV, Smid J, Brucki SMD, Caramelli P, Nitrini R, Engelhardt E, Resende EPF.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Lecanemab in Early Alzheimer’s Disease

New England Journal of Medicine, 2023
Michio Kanekiyo, Larisa Reyderman, Sharon Cohen   +2 more
exaly